Susunod

Auto-play

Dr. Amaria on Genetically Modified TILs in Melanoma

2 Mga view • 07/03/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play